Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.65 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.65 |
| ▸ | PPARG | P37231 | 5/20 | 0.55 |
| ▸ | TERT | O14746 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | PPARD | Q03181 | 3/20 | 0.55 |
| ▸ | PPARA | Q07869 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | F7 | P08709 | 2/20 | 0.55 |
| ▸ | F3 | P13726 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30902072 | 1.00 | FFAR1 (0.65) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL3683366 | 1.00 | FFAR1 (0.65) | FFAR1FFAR4PPARGTERTPTPN1 | |
| Ethylene Glycol SCHEMBL20678202 | 0.97 | FFAR1 (0.61) | FFAR1FFAR4PPARGTERTPTPN1 | |
| Ethylene SCHEMBL10697177 | 0.97 | FFAR1 (0.61) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL3367824 | 0.95 | FFAR1 (0.60) | FFAR1FFAR4PPARGPPARDPPARA | |
| Oleic Acid SCHEMBL29894126 | 0.91 | FFAR1 (0.76) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL30457930 | 0.91 | FFAR1 (0.71) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL30458023 | 0.91 | FFAR1 (0.71) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL10081556 | 0.91 | FFAR1 (0.71) | FFAR1FFAR4PPARGTERTPTPN1 | |
| SCHEMBL30457666 | 0.91 | FFAR1 (0.71) | FFAR1FFAR4PPARGTERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11185504-B2 | Transdermal non-aqueous nanoemulgels for systemic delivery of aromatase inhibitor | QATAR UNIVERSITY (QA) | 2021-11-30 | — | — | US | claimed |
| US-20200390701-A1 | TRANSDERMAL NON-AQUEOUS NANOEMULGELS FOR SYSTEMIC DELIVERY OF AROMATASE INHIBITOR | QATAR UNIVERSITY (QA) | 2020-12-17 | — | — | US | claimed |
| EP-3727363-A1 | TRANSDERMAL NON-AQUEOUS NANOEMULGELS FOR SYSTEMIC DELIVERY OF AROMATASE INHIBITOR | Qatar University (QA) | 2020-10-28 | — | — | EP | claimed |
| WO-2019064090-A1 | NOVEL PHARMACEUTICAL COMPOSITION COMPRISING MEFENAMIC ACID AND OTHER ANALGESIC | ZENVISION PHARMA LLP (IN) | 2019-04-04 | — | — | WO | claimed |
| EP-2658610-B1 | COLLOIDAL CARRIER SYSTEM WITH PENETRATION PROPERTIES FOR ENCAPSULATING LIPOPHILIC ACTIVE AGENTS AND OILS FOR TOPICAL USE | BLUME GABRIELE (DE) | 2016-05-04 | — | — | EP | claimed |
| US-20150313846-A1 | PROLONGED-RELEASE MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM | FLAMEL IRELAND LIMITED (IE) | 2015-11-05 | — | — | US | claimed |
| US-9161921-B2 | Colloidal carrier system with penetration properties for encapsulating lipophilic active agents and oils for topical use | BLUME GABRIELE (DE) | 2015-10-20 | — | — | US | claimed |
| US-20130273123-A1 | Colloidal Carrier System with Penetration Properties for Encapsulating Lipophilic Active Agents and Oils for Topical Use | BLUME GABRIELE (DE) | 2013-10-17 | — | — | US | claimed |
| WO-2012120364-A2 | NOVEL IMMEDIATE RELEASE FILM COATING COMPOSITIONS | IDEAL CURES PVT. LTD. (IN) | 2012-09-13 | — | — | WO | claimed |
| WO-2012120366-A1 | NOVEL MOISTURE BARRIER IMMEDIATE RELEASE FILM COATING COMPOSITION | IDEAL CURES PVT. LTD. (IN) | 2012-09-13 | — | — | WO | claimed |
| EP-0871489-A1 | A PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF AN ACTIVE SUBSTANCE TO OR THROUGH A SKIN OR MUCOSAL SURFACE | GS DEVELOPMENT AB (SE) | 1998-10-21 | — | — | EP | claimed |
| EP-0868173-A1 | SUSTAINED-RELEASE DRUG DELIVERY SYSTEM | Shire Laboratories Inc. (US) | 1998-10-07 | — | — | EP | claimed |
| WO-1997019677-A1 | SUSTAINED-RELEASE DRUG DELIVERY SYSTEM | PHARMAVENE, INC. (US) | 1997-06-05 | — | — | WO | claimed |
| WO-1997013528-A1 | A PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF AN ACTIVE SUBSTANCE TO OR THROUGH A SKIN OR MUCOSAL SURFACE | GS DEVELOPMENT AB (SE) | 1997-04-17 | — | — | WO | claimed |
| EP-0752855-A1 | USE OF FATTY ACID ESTERS AS BIOADHESIVE SUBSTANCES | DUMEX-ALPHARMA A/S (DK) | 1997-01-15 | — | — | EP | claimed |
| US-5484608-A | ACRYLIC POLYMER CARRIERS | PHARMAVENE, INC. (US) | 1996-01-16 | — | — | US | claimed |
| WO-1995026715-A2 | USE OF FATTY ACID ESTERS AS BIOADHESIVE SUBSTANCES | DUMEX-ALPHARMA A/S (DK) | 1995-10-12 | — | — | WO | claimed |
| EP-0493437-B1 | MEDICINAL AEROSOL FORMULATIONS | RIKER LABORATORIES INC (US) | 1995-08-02 | — | — | EP | claimed |
| EP-0493437-A1 | MEDICINAL AEROSOL FORMULATIONS. | RIKER LABORATORIES INC (US) | 1992-07-08 | — | — | EP | claimed |
| WO-1991004011-A1 | MEDICINAL AEROSOL FORMULATIONS | RIKER LABORATORIES, INC. (US) | 1991-04-04 | — | — | WO | claimed |